AZD7442 antibody combination reduces COVID-19 risk by 50 percent
Positive high-level results from the TACKLE Phase III COVID-19 treatment trial...
Read MoreOct 21, 2021 | Clinical Trials
Positive high-level results from the TACKLE Phase III COVID-19 treatment trial...
Read MoreOct 21, 2021 | Clinical Trials
Sanofi has announced positive data from the first study of their high-dose influenza vaccine with...
Read MoreOct 21, 2021 | Clinical Trials
FDA’s fall meeting lineup includes a roster that could impact a broad swath of the...
Read MoreOct 21, 2021 | Clinical Trials
A clinical trial evaluating the effectiveness of Abbott Laboratories’ implantable heart...
Read MoreOct 21, 2021 | Regulatory Affairs
Vaccines should not become a barrier to enter any nation, Suchitra Ella, Joint managing director,...
Read MoreM | T | W | T | F | S | S |
---|---|---|---|---|---|---|
1 | ||||||
2 | 3 | 4 | 5 | 6 | 7 | 8 |
9 | 10 | 11 | 12 | 13 | 14 | 15 |
16 | 17 | 18 | 19 | 20 | 21 | 22 |
23 | 24 | 25 | 26 | 27 | 28 | 29 |
30 | 31 |